B
Bailard Portfolio holdings
AUM
$4.29B
This Quarter Return
-11.77%
1 Year Return
+18.39%
3 Year Return
+76.25%
5 Year Return
+133.74%
10 Year Return
+353.73%
AUM
$1.4B
AUM Growth
+$1.4B
(-21%)
Cap. Flow
-$67.5M
Cap. Flow
% of AUM
-4.81%
Top 10 Holdings %
Top 10 Hldgs %
34.57%
Holding
607
New
76
Increased
144
Reduced
177
Closed
160
Top Buys
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$63.4M |
| 2 |
SPDR Gold Trust
GLD
|
$56.1M |
| 3 |
SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
|
$33.6M |
| 4 |
iShares AAA-A Rated Corporate Bond ETF
QLTA
|
$21.8M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
$16.2M |
Top Sells
Sector Composition
| 1 | Technology | 15.59% |
| 2 | Healthcare | 8.22% |
| 3 | Communication Services | 5.26% |
| 4 | Financials | 4.87% |
| 5 | Consumer Discretionary | 4.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
NorthWestern Energy
NWE
$3.52B
| $431K | 0.03% |
7,200
-1,100
| -13% | -$65.8K |
|
252
Southwest Gas
SWX
$5.68B
| $431K | 0.03% |
6,200
+1,800
| +41% | +$125K |
|
253
Toyota
TM
$252B
| $428K | 0.03% |
3,572
+751
| +27% | +$90K |
|
|
CTLT
254
DELISTED
CATALENT, INC.
CTLT
| $421K | 0.03% |
8,102
| – | – |
|
255
Cousins Properties
CUZ
$4.89B
| $419K | 0.03% |
+14,299
| New | +$419K |
|
256
iShares Biotechnology ETF
IBB
$5.69B
| $418K | 0.03% |
3,880
-472
| -11% | -$50.8K |
|
257
Eli Lilly
LLY
$659B
| $409K | 0.03% |
2,945
-20
| -0.7% | -$2.78K |
|
258
Novartis
NVS
$245B
| $408K | 0.03% |
4,951
-956
| -16% | -$78.8K |
|
259
Salesforce
CRM
$242B
| $406K | 0.03% |
2,822
+179
| +7% | +$25.8K |
|
260
MDU Resources
MDU
$3.33B
| $402K | 0.03% |
18,700
+900
| +5% | +$19.3K |
|
261
GSK
GSK
$78.5B
| $396K | 0.03% |
10,464
+1,776
| +20% | +$67.2K |
|
262
Wells Fargo
WFC
$262B
| $396K | 0.03% |
13,796
-9,225
| -40% | -$265K |
|
263
Douglas Emmett
DEI
$2.71B
| $394K | 0.03% |
+12,900
| New | +$394K |
|
264
iShares Core MSCI Total International Stock ETF
IXUS
$47.5B
| $394K | 0.03% |
8,390
| – | – |
|
265
Blackstone
BX
$132B
| $391K | 0.03% |
8,587
| – | – |
|
266
Duke Energy
DUK
$94.8B
| $390K | 0.03% |
4,824
-275
| -5% | -$22.2K |
|
|
PRVB
267
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $390K | 0.03% |
42,400
-7,900
| -16% | -$72.7K |
|
268
iShares 1-3 Year Treasury Bond ETF
SHY
$24.5B
| $388K | 0.03% |
+4,478
| New | +$388K |
|
|
RC
269
Ready Capital
RC
$702M
| $384K | 0.03% |
53,139
| – | – |
|
270
Alnylam Pharmaceuticals
ALNY
$58.6B
| $381K | 0.03% |
3,500
| – | – |
|
271
McCormick & Company Non-Voting
MKC
$18.5B
| $377K | 0.03% |
2,671
-759
| -22% | -$107K |
|
272
Alliant Energy
LNT
$16.6B
| $370K | 0.03% |
7,660
+2,066
| +37% | +$99.8K |
|
273
Vanguard Global ex-US Real Estate ETF
VNQI
$3.51B
| $369K | 0.03% |
8,604
-1,655
| -16% | -$71K |
|
274
Arvinas
ARVN
$580M
| $367K | 0.03% |
9,100
-4,900
| -35% | -$198K |
|
275
SPDR S&P 500 Fossil Fuel Free ETF
SPYX
$2.29B
| $367K | 0.03% |
5,750
-10,585
| -65% | -$676K |
|